About
Signe Modvig Stausbøll serves as a Clinical Associate Professor in the Department of Clinical Medicine at the University of Copenhagen, specializing in Clinical Immunology with clinical appointments at the Capital Region of Denmark hospitals. Her research bridges laboratory science and clinical practice through active collaborations across Danish medical institutions.
Her work spans immunology, oncology, and neurology with emphasis on cancer immunotherapy for acute lymphoblastic leukemia (ALL), neuroimmunology in multiple sclerosis, and advanced genomic/proteomic methodologies. Key interests include neo-antigen vaccine development, neurofilament light chain biomarker validation, single-cell analysis of leukemia subtypes, and proteomic profiling of pediatric CNS tumors. This interdisciplinary approach integrates molecular diagnostics with therapeutic innovation.
Recent publications reveal a pronounced trend toward translational research combining cutting-edge omics technologies with clinical cohort studies. Her 2024-2025 work demonstrates particular focus on biomarker dynamics in preclinical neuroinflammatory conditions and genomic vulnerabilities in ALL subtypes, highlighting strategic applications of single-cell technologies for therapeutic targeting in hematologic malignancies.
